Welcome to Westonci.ca, your go-to destination for finding answers to all your questions. Join our expert community today! Discover comprehensive answers to your questions from knowledgeable professionals on our user-friendly platform. Connect with a community of professionals ready to help you find accurate solutions to your questions quickly and efficiently.

an obese client has asked the nurse practitioner to prescribe sibutramine. what variable will most affect the nurse's decision?

Sagot :

The fact that sibutramine has been withdrawn from the market due to adverse cardiovascular effects will have the greatest impact on the nurse's decision.

Cardiovascular disease (CVD) is a broad term for any condition affecting the heart or blood vessels. Blood flow to the heart, brain, or body can be reduced due to a blood clot (thrombosis), fatty deposit buildup inside an artery, which causes the artery to harden and narrow (atherosclerosis)

Sibutramine, formerly known as Meridia among other brand names, is an appetite suppressant that has been phased out in many countries. Until 2010, it was widely marketed but also prescribed as an adjunct to diet and exercise in the treatment of obesity.

Chest pain and discomfort, upper neck and back pain, indigestion, heartburn, stomach problems, extreme fatigue, upper body discomfort, dizziness, as well as shortness of breath are all symptoms of a heart attack. Arrhythmia is characterized by fluttering sensations in the chest (palpitations).

To know more about the Cardiovascular ,here

https://brainly.com/question/1323797

#SPJ4